focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

Wed, 08th Dec 2021 11:45

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Rockhopper Exploration PLC, up 22% at 6.38 pence, 12-month range 4.50p-12.50p. The oil & gas exploration and production company says Navitas Petroleum LP is to enter its Sea Lion oil project in the Falkland Islands. Navitas replaces Harbour Energy PLC as Rockhopper's partner in the project.

----------

Equals Group PLC, up 12% at 70.40p, 12-month range 26.10p-73.00. The fintech payments firm says it has "significantly exceeded" its full-year expectations for both adjusted earnings and revenue. Group revenue for the year to date is GBP40.4 million, up 51% from GBP26.8 million for the same period in 2020. The strong revenue performance means increased gross profit and earnings, and Equals says it has exceeded its own full-year profitability forecasts, but does not provide a figure.

----------

Clinigen Group PLC, up 10% at 901.00p, 12-month range 541.50p-912.00p. Shares hit 12-month high after the pharmaceuticals and services provider agrees to be taken private by European investment firm Triton Funds in a GBP1.2 billion deal. Under the terms, Clinigen shareholders will receive 883p a share in cash. This is a 41% premium to the ex-dividend closing share price on December 1, which was the last business day before takeover talks were first announced. Clinigen shareholders will also be entitled to receive the previously declared final dividend of 5.46p a share.

----------

AIM - LOSERS

----------

Byotrol PLC, down 16% at 4.22p, 12-month range 4.00p-7.70p. Shares in the antimicrobial technologies company hit fresh 12-month low after profit warning and says its first half performance was below expectations. For six months to September 30, swings to pretax loss of GBP141,000 from GBP1.0 million profit year before. "Whilst we expect to be both profitable and cash generative in the second half of the year, with these uncertainties it is difficult to predict the quantum at this juncture. At present we are expecting IP sales to offset the majority of the anticipated shortfall in profit on product sale, but projecting the timing of IP sales is even more uncertain, so we feel it prudent to now reduce market guidance for the current financial year," it says.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Dec 2021 08:16

Clinigen to be taken private by Triton in £1.2bn deal, shares surge

(Sharecast News) - Clinigen surged on Wednesday after agreeing to be taken private by European investment firm Triton in a £1.2bn deal.

Read more
2 Dec 2021 14:28

Shares in Clinigen surge on takeover talks with Triton Investment

Shares in Clinigen surge on takeover talks with Triton Investment

Read more
2 Dec 2021 12:59

Clinigen confirms takeover talks with Triton, shares surge

(Sharecast News) - Clinigen shares surged on Thursday after the company confirmed it has received a non-binding indicative proposal from investment firm Triton about a possible offer.

Read more
2 Dec 2021 09:52

LONDON BROKER RATINGS: Upgrades for Old Mutual and Superdry; Drax cut

LONDON BROKER RATINGS: Upgrades for Old Mutual and Superdry; Drax cut

Read more
1 Dec 2021 13:42

Clinigen's leukaemia treatment Erwinase fails to gain approval in US

Clinigen's leukaemia treatment Erwinase fails to gain approval in US

Read more
29 Nov 2021 11:21

Clinigen signs exclusive agreement with Nippon Shinyaku on Viltepso

Clinigen signs exclusive agreement with Nippon Shinyaku on Viltepso

Read more
25 Nov 2021 16:01

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
17 Nov 2021 16:01

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
5 Nov 2021 09:55

Liberum lowers target price on Clinigen

(Sharecast News) - Analysts at Liberum lowered their target price on pharmaceutical services and products group Clinigen from 886.0p to 800.0p on Friday but stated risks still appeared to be "skewed to the upside".

Read more
8 Oct 2021 08:46

Clinigen and Humanigen partner to progress investigational Covid drug

Clinigen and Humanigen partner to progress investigational Covid drug

Read more
22 Sep 2021 19:31

TRADING UPDATES: Clinigen signs Copiktra deal; Alien "really pleased"

TRADING UPDATES: Clinigen signs Copiktra deal; Alien "really pleased"

Read more
22 Sep 2021 13:34

Clinigen to distribute 'Copiktra' in most of Europe

(Sharecast News) - Pharmaceutical products and services provider Clinigen has signed an exclusive agreement with Secura Bio for the supply and distribution of 'Copiktra' in most of Europe, it announced on Wednesday.

Read more
16 Sep 2021 12:29

Clinigen cuts full-year earnings forecasts, shares fall

(Sharecast News) - Shares in Clinigen Group fell on Thursday after the pharmaceuticals specialist cut its full-year earnings forecast.

Read more
16 Sep 2021 12:07

Clinigen shares fall on lowered outlook as profit more than doubles

Clinigen shares fall on lowered outlook as profit more than doubles

Read more
16 Sep 2021 10:55

AIM WINNERS & LOSERS: Kibo invests in Eqtec project; Clinigen falls

AIM WINNERS & LOSERS: Kibo invests in Eqtec project; Clinigen falls

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.